Literature DB >> 19136708

Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival?

Xian Zhang1, Linling Shen, Yiping Jin, Daniel R Saban, Sunil K Chauhan, Reza Dana.   

Abstract

PURPOSE: To develop and compare effective strategies for depleting graft-derived passenger leukocytes that include antigen-presenting cells from corneal buttons and to assess the effectiveness of this strategy in promoting graft survival using a high-risk (HR) model of corneal transplantation.
METHODS: Corneal buttons harvested from C57BL/6 mice were used in three ex vivo strategies of passenger leukocyte depletion. Two strategies involved storage in medium at different temperatures for prolonged periods. A third strategy used complement-dependent cytotoxicity (CDC) by treating the buttons with anti-CD45 mAb plus complement. Wholemount corneal buttons or cells from enzyme-digested corneas were analyzed using confocal microscopy or flow cytometry, respectively, for the pan-leukocyte surface marker CD45. HR host beds were created and used to evaluate the efficacy of passenger leukocyte depletion on transplant survival.
RESULTS: Passenger leukocyte numbers in the buttons were significantly reduced by all three treatments. CDC was the most efficient strategy for passenger leukocyte depletion with 39% reduction (P < 0.00005) of CD45(+) cells, and negligible damage to the endothelial layer, achievable within 24 hours. However, passenger leukocyte depletion failed to improve HR graft longevity.
CONCLUSIONS: Anti-CD45 antibody plus complement-mediated targeting of donor tissue is the most efficient way to deplete corneal passenger leukocytes and can considerably reduce the time required for cell depletion. However, depletion of graft passenger leukocytes does not have a significant effect on promoting graft survival even in the HR setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136708      PMCID: PMC2739689          DOI: 10.1167/iovs.08-1899

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

1.  Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.

Authors:  F Boisgérault; Y Liu; N Anosova; E Ehrlich; M R Dana; G Benichou
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

2.  Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation.

Authors:  Gerald G Wulf; Kang-Li Luo; Margaret A Goodell; Malcolm K Brenner
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 3.  Dendritic cells, tolerance induction and transplant outcome.

Authors:  P Toby H Coates; Angus W Thomson
Journal:  Am J Transplant       Date:  2002-04       Impact factor: 8.086

Review 4.  Pathways of allorecognition: implications for transplantation tolerance.

Authors:  David S Game; Robert I Lechler
Journal:  Transpl Immunol       Date:  2002-08       Impact factor: 1.708

5.  Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.

Authors:  Pedram Hamrah; Qiang Zhang; Ying Liu; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

Review 6.  Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection.

Authors:  M R Dana; Y Qian; P Hamrah
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

7.  Effects of penetrating keratoplasty rejection on the endothelium of the donor cornea and the recipient peripheral cornea.

Authors:  N Ohguro; M Matsuda; Y Shimomura; Y Inoue; Y Tano
Journal:  Am J Ophthalmol       Date:  2000-04       Impact factor: 5.258

8.  Identification of a novel macrophage population in the normal mouse corneal stroma.

Authors:  Cynthia S Brissette-Storkus; Stephanie M Reynolds; Andrew J Lepisto; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

9.  Turnover of bone marrow-derived cells in the irradiated mouse cornea.

Authors:  Holly R Chinnery; Timothy Humphries; Adam Clare; Ariane E Dixon; Kristen Howes; Caitlin B Moran; Danielle Scott; Marianna Zakrzewski; Eric Pearlman; Paul G McMenamin
Journal:  Immunology       Date:  2008-06-06       Impact factor: 7.397

10.  Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts.

Authors:  Ying Liu; Pedram Hamrah; Qiang Zhang; Andrew W Taylor; M Reza Dana
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  12 in total

Review 1.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 2.  Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.

Authors:  Maryam Tahvildari; Afsaneh Amouzegar; William Foulsham; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2018-01-06       Impact factor: 9.261

Review 3.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

4.  Gamma-irradiation reduces the allogenicity of donor corneas.

Authors:  William Stevenson; Sheng-Fu Cheng; Parisa Emami-Naeini; Jing Hua; Eleftherios I Paschalis; Reza Dana; Daniel R Saban
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

5.  IL-17 promotes immune privilege of corneal allografts.

Authors:  Khrishen Cunnusamy; Peter W Chen; Jerry Y Niederkorn
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

6.  The ocular surface phenotype of Muc5ac and Muc5b null mice.

Authors:  Christina Kaiser Marko; Ann S Tisdale; Sandra Spurr-Michaud; Christopher Evans; Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-15       Impact factor: 4.799

7.  Spdef null mice lack conjunctival goblet cells and provide a model of dry eye.

Authors:  Christina K Marko; Balaraj B Menon; Gang Chen; Jeffrey A Whitsett; Hans Clevers; Ilene K Gipson
Journal:  Am J Pathol       Date:  2013-05-10       Impact factor: 4.307

8.  Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation.

Authors:  Maryam Tahvildari; Parisa Emami-Naeini; Masahiro Omoto; Alireza Mashaghi; Sunil K Chauhan; Reza Dana
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 9.  Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Authors:  Tulio B Abud; Antonio Di Zazzo; Ahmad Kheirkhah; Reza Dana
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

10.  Time- and Stimulus-Dependent Characteristics of Innate Immune Cells in Organ-Cultured Human Corneal Tissue.

Authors:  Xinyu Zhuang; Günther Schlunck; Julian Wolf; Dennis-Dominik Rosmus; Tim Bleul; Ren Luo; Daniel Böhringer; Peter Wieghofer; Clemens Lange; Thomas Reinhard; Thabo Lapp
Journal:  J Innate Immun       Date:  2021-06-28       Impact factor: 7.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.